Amgen
AMGN
2,195 hedge funds and large institutions have $105B invested in Amgen in 2021 Q2 according to their latest regulatory filings, with 117 funds opening new positions, 896 increasing their positions, 861 reducing their positions, and 114 closing their positions.
19% more call options, than puts
Call options by funds: $1.38B | Put options by funds: $1.16B
4% more repeat investments, than reductions
Existing positions increased: 896 | Existing positions reduced: 861
3% more first-time investments, than exits
New positions opened: 117 | Existing positions closed: 114
0.8% less ownership
Funds ownership: 76.27% → 75.47% (-0.8%)
3% less capital invested
Capital invested by funds: $109B → $105B (-$3.69B)
1% less funds holding
Funds holding: 2,218 → 2,195 (-23)
19% less funds holding in top 10
Funds holding in top 10: 53 → 43 (-10)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Advisers
New York
|
+$305M |
| 2 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$269M |
| 3 |
Two Sigma Investments
New York
|
+$231M |
| 4 |
Charles Schwab
San Francisco,
California
|
+$214M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$178M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$814M |
| 2 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$317M |
| 3 |
ClearBridge Investments
New York
|
-$246M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$244M |
| 5 |
Nordea Investment Management
Stockholm,
Sweden
|
-$243M |
AMGN Hedge Fund Activity: Q2 2021 in Review
2,195 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Amgen (AMGN) for Q2 2021, worth a combined $105B — down 3.4% from $109B a quarter earlier.
Buyers outnumbered sellers: 117 funds opened new AMGN positions and 114 closed out — a net gain of 3 holders — while 896 added to existing stakes and 861 trimmed.
The largest buyer was Two Sigma Advisers, adding an estimated $305M. The largest seller was Capital Research Global Investors, cutting an estimated $814M.
- 2,195 institutional investors held Amgen (AMGN) as of Q2 2021, down from 2,218 in Q1 2021.
- Funds reported $105B of Amgen stock for Q2 2021, down 3.4% quarter-over-quarter.
- 117 funds opened new Amgen positions in Q2 2021 and 114 closed out, a net change of +3 holders.
- The largest Amgen buyer in Q2 2021 was Two Sigma Advisers, an estimated $305M added.
- The largest Amgen seller in Q2 2021 was Capital Research Global Investors, an estimated $814M sold.
Based on aggregated 13F filings for Q2 2021.